Annual EBIT:
-$179.93M-$110.53M(-159.27%)Summary
- As of today, OCUL annual earnings before interest & taxes is -$179.93 million, with the most recent change of -$110.53 million (-159.27%) on December 31, 2024.
- During the last 3 years, OCUL annual EBIT has fallen by -$180.05 million (-152582.20%).
- OCUL annual EBIT is now -152582.20% below its all-time high of $118.00 thousand, reached on December 31, 2021.
Performance
OCUL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$68.70M-$1.06M(-1.56%)Summary
- As of today, OCUL quarterly earnings before interest & taxes is -$68.70 million, with the most recent change of -$1.06 million (-1.56%) on September 30, 2025.
- Over the past year, OCUL quarterly EBIT has dropped by -$22.70 million (-49.35%).
- OCUL quarterly EBIT is now -2198.36% below its all-time high of -$2.99 million, reached on June 30, 2013.
Performance
OCUL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$250.83M-$22.70M(-9.95%)Summary
- As of today, OCUL TTM earnings before interest & taxes is -$250.83 million, with the most recent change of -$22.70 million (-9.95%) on September 30, 2025.
- Over the past year, OCUL TTM EBIT has dropped by -$109.58 million (-77.58%).
- OCUL TTM EBIT is now -8097.12% below its all-time high of -$3.06 million, reached on March 31, 2013.
Performance
OCUL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
OCUL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -159.3% | -49.4% | -77.6% |
| 3Y3 Years | -10000.0% | -218.9% | -224.3% |
| 5Y5 Years | -124.2% | -390.5% | -258.8% |
OCUL EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | >-9999.0% | at low | -257.5% | at low | -224.3% | at low |
| 5Y | 5-Year | >-9999.0% | at low | -390.5% | at low | -299.1% | at low |
| All-Time | All-Time | >-9999.0% | at low | -2198.4% | at low | -8097.1% | at low |
OCUL EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$68.70M(-1.6%) | -$250.83M(-10.0%) |
| Jun 2025 | - | -$67.64M(-5.8%) | -$228.13M(-11.8%) |
| Mar 2025 | - | -$63.92M(-26.4%) | -$204.08M(-18.8%) |
| Dec 2024 | -$179.93M(-159.3%) | -$50.58M(-10.0%) | -$171.78M(-21.6%) |
| Sep 2024 | - | -$46.00M(-5.5%) | -$141.25M(-23.4%) |
| Jun 2024 | - | -$43.59M(-37.9%) | -$114.47M(-25.2%) |
| Mar 2024 | - | -$31.62M(-57.7%) | -$91.45M(-11.0%) |
| Dec 2023 | -$69.40M(-8.4%) | -$20.05M(-4.3%) | -$82.38M(-0.8%) |
| Sep 2023 | - | -$19.21M(+6.6%) | -$81.69M(+2.8%) |
| Jun 2023 | - | -$20.57M(+8.8%) | -$84.02M(-0.8%) |
| Mar 2023 | - | -$22.55M(-16.5%) | -$83.37M(-6.0%) |
| Dec 2022 | -$64.02M(>-9900.0%) | -$19.36M(+10.1%) | -$78.65M(-1.7%) |
| Sep 2022 | - | -$21.54M(-8.2%) | -$77.34M(-2.7%) |
| Jun 2022 | - | -$19.92M(-11.7%) | -$75.33M(+0.4%) |
| Mar 2022 | - | -$17.83M(+1.2%) | -$75.64M(+3.1%) |
| Dec 2021 | $118.00K(+100.1%) | -$18.05M(+7.6%) | -$78.03M(-5.0%) |
| Sep 2021 | - | -$19.53M(+3.5%) | -$74.33M(-8.0%) |
| Jun 2021 | - | -$20.23M(-0.0%) | -$68.81M(-3.5%) |
| Mar 2021 | - | -$20.23M(-41.0%) | -$66.46M(-5.8%) |
| Dec 2020 | -$148.87M(-85.5%) | -$14.34M(-2.4%) | -$62.85M(+10.1%) |
| Sep 2020 | - | -$14.01M(+21.7%) | -$69.91M(+11.6%) |
| Jun 2020 | - | -$17.88M(-7.6%) | -$79.04M(+4.5%) |
| Mar 2020 | - | -$16.61M(+22.4%) | -$82.76M(+3.5%) |
| Dec 2019 | -$80.27M | -$21.40M(+7.5%) | -$85.80M(-5.0%) |
| Sep 2019 | - | -$23.14M(-7.2%) | -$81.68M(-11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$21.60M(-9.9%) | -$73.36M(-12.3%) |
| Mar 2019 | - | -$19.66M(-13.7%) | -$65.32M(-10.5%) |
| Dec 2018 | -$58.24M(+5.3%) | -$17.28M(-16.7%) | -$59.12M(-9.2%) |
| Sep 2018 | - | -$14.82M(-9.2%) | -$54.13M(-3.3%) |
| Jun 2018 | - | -$13.56M(-0.8%) | -$52.42M(+8.3%) |
| Mar 2018 | - | -$13.46M(-9.4%) | -$57.20M(+3.7%) |
| Dec 2017 | -$61.49M(-42.9%) | -$12.30M(+6.2%) | -$59.42M(+0.3%) |
| Sep 2017 | - | -$13.11M(+28.5%) | -$59.59M(-6.9%) |
| Jun 2017 | - | -$18.34M(-17.0%) | -$55.72M(-14.7%) |
| Mar 2017 | - | -$15.67M(-25.7%) | -$48.59M(-11.9%) |
| Dec 2016 | -$43.02M(-13.1%) | -$12.47M(-35.0%) | -$43.43M(-5.3%) |
| Sep 2016 | - | -$9.24M(+17.6%) | -$41.23M(+4.5%) |
| Jun 2016 | - | -$11.21M(-6.7%) | -$43.17M(-3.8%) |
| Mar 2016 | - | -$10.51M(-2.3%) | -$41.59M(-8.9%) |
| Dec 2015 | -$38.02M(-38.1%) | -$10.28M(+8.0%) | -$38.20M(-7.7%) |
| Sep 2015 | - | -$11.17M(-16.0%) | -$35.47M(-14.2%) |
| Jun 2015 | - | -$9.63M(-35.5%) | -$31.07M(-13.5%) |
| Mar 2015 | - | -$7.11M(+5.8%) | -$27.38M(-1.1%) |
| Dec 2014 | -$27.53M(-113.8%) | -$7.55M(-11.4%) | -$27.09M(-38.6%) |
| Sep 2014 | - | -$6.78M(-14.0%) | -$19.55M(-53.1%) |
| Jun 2014 | - | -$5.95M(+12.9%) | -$12.77M(-30.1%) |
| Mar 2014 | - | -$6.83M(-128.3%) | -$9.81M(-62.2%) |
| Dec 2013 | -$12.88M(+6.1%) | - | - |
| Jun 2013 | - | -$2.99M(+2.3%) | -$6.05M(-97.7%) |
| Mar 2013 | - | -$3.06M | -$3.06M |
| Dec 2012 | -$13.72M | - | - |
FAQ
- What is Ocular Therapeutix, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. annual EBIT year-on-year change?
- What is Ocular Therapeutix, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. quarterly EBIT year-on-year change?
- What is Ocular Therapeutix, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. TTM EBIT year-on-year change?
What is Ocular Therapeutix, Inc. annual earnings before interest & taxes?
The current annual EBIT of OCUL is -$179.93M
What is the all-time high annual EBIT for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high annual earnings before interest & taxes is $118.00K
What is Ocular Therapeutix, Inc. annual EBIT year-on-year change?
Over the past year, OCUL annual earnings before interest & taxes has changed by -$110.53M (-159.27%)
What is Ocular Therapeutix, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of OCUL is -$68.70M
What is the all-time high quarterly EBIT for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high quarterly earnings before interest & taxes is -$2.99M
What is Ocular Therapeutix, Inc. quarterly EBIT year-on-year change?
Over the past year, OCUL quarterly earnings before interest & taxes has changed by -$22.70M (-49.35%)
What is Ocular Therapeutix, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of OCUL is -$250.83M
What is the all-time high TTM EBIT for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high TTM earnings before interest & taxes is -$3.06M
What is Ocular Therapeutix, Inc. TTM EBIT year-on-year change?
Over the past year, OCUL TTM earnings before interest & taxes has changed by -$109.58M (-77.58%)